PASG

Passage Bio, Inc.

7.03

-0.34-4.61%

Pre Market: 7.75 +0.72 +10.24%08:13 03/19 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE7.68/7.37

TODAY RANGE6.77-7.68

VOL89

MARKET CAP22.55M

52 WEEK RANGE5.12-20.00

AVG VOL (3M)56.88K

% TURNOVER0.74%

TURNOVER0

P/E (TTM)-0.4900

% RANGE12.35%

EPS(TTM)-14.3473

P/E(FORWARD)-1.0064

P/B1.193

BVPS5.89

DIVIDEND--

P/S--

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP22.44M

SHARES OUTSTANDING3.21M

NEXT EARNINGS05/11-05/15

FREE FLOAT3.19M

LOT SIZE1

EX-DATE07/14/2025

News

Press Releases

Financial Reports

Profile

TipRanks·03/10 11:55
Passage Bio Ends Hopewell Lab Lease, Extends Cash Runway
Dow Jones·03/04 19:11
Passage Bio Price Target Cut to $23.00/Share From $67.00 by Canaccord Genuity
Dow Jones·03/04 19:11
Passage Bio Is Maintained at Buy by Canaccord Genuity
TipRanks·03/04 12:21
Passage Bio price target lowered to $23 from $67 at Canaccord
TipRanks·03/04 08:16
Passage Bio (PASG) Gets a Buy from Chardan Capital
TipRanks·03/03 22:30
Analysts Are Bullish on These Healthcare Stocks: Upstream Bio, Inc. (UPB), Passage Bio (PASG)
TipRanks·03/03 20:10
Analysts Are Bullish on These Healthcare Stocks: Esperion (ESPR), Passage Bio (PASG)
Seeking Alpha·03/03 20:03
Passage Bio GAAP EPS of -$4.09
TipRanks·03/03 12:42
Passage Bio Reports 2025 Results, Advances FTD Program
Reuters·03/03 12:10
Passage Bio's 2025 net loss narrows
Reuters·03/03 12:02
Passage Bio FY 2025 net loss totals USD 45.5 million -29.7%
Dow Jones·03/03 12:02
*Passage Bio 4Q Research and Development Expenses $5.4M >PASG
Dow Jones·03/03 12:02
*Passage Bio 4Q Loss/Shr $4.09 >PASG
Dow Jones·03/03 12:00
Press Release: Passage Bio Reports Fourth Quarter -2-
Dow Jones·03/03 12:00
Press Release: Passage Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Recent Business Highlights

Same Industry

Name/Symbol

Change%

Price

PASG

REGN

GRDX

BIONTECH

BNTX

-5.12%

90.00

United Therapeutics Corp.

UTHR

-1.79%

530.35

VRTX

Siga Technologie

SIGA

+3.23%

5.43

MRNA

CRL

Medpace Holdings

MEDP

-0.08%

454.80

Talphera Inc

TLPH

-0.20%

0.7952

ICLR

CBPO

IQV

MOLN

Arcturus Therape

ARCT

-3.47%

6.40

GILD

PRAH

INCY

APVO

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.